Polycystic Ovary Syndrome (PCOS) is a common endocrine metabolic disorder that primarily affects women of reproductive age. Its characteristics include hormonal imbalance, ovarian dysfunction, and metabolic abnormalities. This condition not only impacts reproductive health but may also lead to long-term metabolic issues such as diabetes or cardiovascular diseases, making early diagnosis and treatment crucial.
According to statistics, approximately 5-10% of women of reproductive age worldwide are affected by this condition, but clinical manifestations vary widely, often leading to misdiagnosis or delayed treatment. This article will comprehensively analyze key information about Polycystic Ovary Syndrome, covering its causes, symptoms, diagnosis, treatment, and prevention, to help readers establish a correct understanding of the disease.
The causes of Polycystic Ovary Syndrome are complex, involving interactions among genetics, hormonal imbalance, and metabolic abnormalities. Research shows that genetic predisposition accounts for about 70% of the risk of developing the condition; if a direct relative in the family has had this condition, the individual's likelihood of developing it significantly increases. In terms of hormones, patients often exhibit excessive secretion of male hormones, leading to the inability of the ovaries to ovulate normally, resulting in the accumulation of immature follicles in the ovaries, creating the "polycystic" phenomenon.
In addition to genetic factors, insulin resistance is a key triggering factor. About 60-70% of patients have insulin resistance issues, leading to abnormal glucose metabolism, which in turn stimulates the adrenal glands to secrete more male hormones. Other risk factors include obesity, poor dietary habits, and lack of exercise, which may exacerbate metabolic abnormalities, creating a vicious cycle. Recent studies have also indicated that chronic inflammatory responses and gut microbiome imbalances may be related to the development of symptoms.
The symptoms of Polycystic Ovary Syndrome present a high degree of variability. Typical symptoms include menstrual cycle irregularities, such as cycles longer than 35 days, amenorrhea, or irregular bleeding. About 70% of patients exhibit signs of masculinization, including hirsutism (increased hair growth around the lips and lower body), acne, or male-pattern baldness. Some patients may observe more than 12 small cystic structures in the ovaries on ultrasound imaging.
Metabolic abnormal symptoms include weight gain, abdominal obesity, and the appearance of dark skin patches (on the neck, underarms, etc.). In severe cases, lipid metabolism abnormalities may accompany, such as elevated LDL cholesterol or triglyceride levels. About 30-50% of patients will exhibit insulin resistance, and these patients are at a 5-10 times higher risk of developing type 2 diabetes compared to the general population.
It is worth noting that about 20-30% of patients present atypical symptoms, which may only show mild menstrual irregularities or slight hirsutism, making early diagnosis more challenging. Some patients may delay seeking medical attention due to mild symptoms, leading to an increased risk of metabolic complications.
Diagnosing Polycystic Ovary Syndrome requires integrating clinical symptoms, laboratory tests, and imaging results. According to the internationally recognized "Rotterdam criteria," diagnosis must meet at least two of the following three indicators: 1. Menstrual irregularities (anovulation or oligomenorrhea); 2. Excess male hormones or related symptoms (such as hirsutism); 3. Ultrasound findings of polycystic ovarian structures.
Blood tests are a key diagnostic tool, measuring male hormones (such as testosterone), the ratio of luteinizing hormone (LH) to follicle-stimulating hormone (FSH), and insulin resistance-related indicators such as fasting blood glucose and insulin levels. Ultrasound examination should observe whether the ovaries present a "pear-shaped" morphology or if there are more than 12 follicles measuring 2-9mm in one ovary.
During diagnosis, other diseases with similar symptoms, such as congenital adrenal hyperplasia, Cushing's syndrome, or androgen-secreting tumors, must be ruled out. For suspected cases, doctors may arrange advanced tests such as a 24-hour urinary free cortisol test or adrenal stimulation tests to ensure diagnostic accuracy.
Treatment for Polycystic Ovary Syndrome should be personalized based on the patient's age, severity of symptoms, and fertility needs. First-line treatment often begins with lifestyle adjustments, including a low glycemic index (GI) diet (such as increasing fiber intake and reducing refined sugars) and regular aerobic exercise (recommended 150 minutes of moderate-intensity exercise per week), which can effectively improve insulin resistance and alleviate symptoms.
In terms of medication, oral contraceptives (such as combination pills containing estrogen and progesterone) can regulate male hormone levels, improve hirsutism, and normalize menstrual cycles. For patients with fertility needs, ovulation-inducing agents (such as clomiphene) can promote ovulation. For those with severe insulin resistance, doctors may prescribe metformin, which can restore cellular sensitivity to insulin and reduce male hormone secretion.
Surgical treatment is often used for severe cases where medication is ineffective. Laparoscopic ovarian drilling improves ovulation function by ablating ovarian tissue but may carry risks such as infection or adhesions. New treatment strategies include metabolic modulators such as GLP-1 receptor agonists or SGLT2 inhibitors, which can simultaneously improve metabolic abnormalities and symptoms.
Although genetic factors cannot be changed, lifestyle adjustments can effectively reduce the severity of symptoms. Maintaining a healthy weight (BMI between 18.5-24.9) can significantly improve insulin sensitivity. It is recommended to adopt a "Mediterranean diet" pattern, increasing whole grains, quality proteins, and unsaturated fatty acids. Regular exercise can enhance mitochondrial function and improve cellular response to insulin.
Regular metabolic screening is key to preventing complications, with recommendations to measure fasting blood glucose, HbA1c, and lipid indices annually. For those with a family history, monitoring menstrual cycle regularity should begin after age 18. Avoiding exposure to environmental hormones (such as bisphenol A in plastic containers and cosmetics) may help reduce symptom triggers.
Psychological support is equally important, as changes in appearance due to symptoms may trigger anxiety or harm self-esteem. Professional counseling can help patients establish a positive attitude towards life. Traditional Chinese medicine treatments such as acupuncture and herbal therapy can serve as adjunctive treatments but should be conducted under physician supervision.
Immediate medical attention should be sought when the following symptoms occur: menstrual cycles longer than 35 days, persistent acne or skin darkening, unexplained weight gain or abdominal obesity, and the appearance of masculinization features (such as prominent Adam's apple or abnormal hair distribution). If planning to conceive but experiencing prolonged difficulty, or if abnormal blood glucose indicators (such as fasting blood glucose ≥100mg/dL) are detected, proactive medical consultation is also advised.
Screening is recommended for those who meet the following criteria: a family history of PCOS, a BMI over 27 accompanied by irregular menstruation, or unexplained hirsutism. Early diagnosis can effectively control the condition through medication and lifestyle adjustments, delaying the development of metabolic complications.
If severe complications have already occurred, such as worsening dysmenorrhea, rapid enlargement of ovarian cysts, or the onset of diabetic complications like retinopathy, immediate evaluation in obstetrics and gynecology or endocrinology clinics is necessary. Regular follow-ups can help timely adjust treatment plans and prevent symptom deterioration.
It is recommended to adopt a low-carbohydrate, high-fiber dietary structure and choose low glycemic index (GI) foods to control blood sugar fluctuations. Increasing intake of deep-sea fish, nuts, and leafy vegetables while limiting refined sugars and processed foods can help improve insulin resistance. Consulting a nutritionist to develop a personalized dietary plan is advised.
What are the differences in the effects of aerobic exercise and resistance training on Polycystic Ovary Syndrome?Aerobic exercise effectively reduces body fat percentage and improves insulin sensitivity, with a recommendation of 150 minutes of moderate-intensity exercise (such as jogging or swimming) per week. Resistance training can increase muscle mass and promote basal metabolism, recommended 2-3 times a week. Combining both types of exercise can comprehensively improve metabolic abnormalities.
What potential risks are associated with long-term use of oral contraceptives for treating Polycystic Ovary Syndrome?Oral contraceptives may slightly increase the risk of blood clots, and long-term use requires regular monitoring of blood coagulation indices. Some patients may experience elevated blood pressure or lipid abnormalities; it is recommended to undergo health checks every 3-6 months and discuss treatment plan adjustments with a physician.
Will the symptoms of Polycystic Ovary Syndrome naturally alleviate with age?Some patients' symptoms of excessive male hormones may ease with age and hormonal changes, but insulin resistance and metabolic issues may persist. Continuous monitoring of weight, blood glucose, and metabolic indicators, along with maintaining a healthy lifestyle, is recommended to avoid complications.
What is the chance of natural conception for patients with Polycystic Ovary Syndrome?About 70% of patients can conceive naturally after lifestyle adjustments and ovulation induction treatment, with the key being the restoration of regular ovulation cycles. Physicians may recommend ovulation-inducing medications or lifestyle adjustments (such as weight control), with successful cases often occurring in patients who receive proactive treatment early on.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
